NCT00001378View on ClinicalTrials.gov

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

January 31, 1994

Study Completion Date

November 30, 2000

Conditions

Breast CancerBreast Neoplasms

Interventions

DRUG

fenretinide

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH